[1] Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases[J]. Neurosurgery, 1988, 23:545-556. [2] Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131:803-820. [3] Luzzi S, Elia A, Del Maestro M, Elbabaa SK, Carnevale S, Guerrini, Caulo M, Morbini P, Galzio R. Dysembryoplastic neuroepithelial tumors: what you need to know[J]. World Neurosurg, 2019, 127:255-265. [4] Isler C, Erturk Cetin O, Ugurlar D, Ozkara C, Comunoglu N,Kizilkilic O, Oz B, Kayadibi Y, Tanriverdi T, Uzan M. Dysembryoplastic neuroepithelial tumours: clinical, radiological, pathological features and outcome[J]. Br J Neurosurg, 2018, 32: 436-441. [5] Zheng Z, Wang X, Sang L, Li DZ, Yang XL, Ma YS, Zhang JG, Zhang K, Li JJ. Surgical treatment of epilepsy due to dysembryoplastic neuroepithelial tumor and prognosis of seizure outcome[J]. Lin Chuang Shen Jing Wai Ke Za Zhi, 2019, 16: 315-319.[郑重, 王秀, 桑林, 李冬智, 杨晓丽, 马延山, 张建国,张凯, 李敬军. 胚胎发育不良性神经上皮肿瘤继发癫痫的手术疗效及预后影响因素分析[J]. 临床神经外科杂志, 2019, 16: 315-319.] [6] Daumas-Duport C, Varlet P, Bacha S, Beuvon F, Cervera-Pierot P, Chodkiewicz JP. Dysembryoplastic neuroepithelial tumors: nonspecific histological forms. A study of 40 cases[J]. J Neurooncol, 1999, 41:267-280. [7] Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology[J].Epilepsia, 2017, 58:512-521. [8] Chassoux F, Rodrigo S, Mellerio C, Landré E, Miquel C, Turak B, Laschet J, Meder JF, Roux FX, Daumas-Duport C, Devaux B. Dysembryoplastic neuroepithelial tumors: an MRI-based scheme for epilepsy surgery[J]. Neurology, 2012, 79:1699-1707. [9] Engel J Jr. Clinical neurophysiology, neuroimaging, and the surgical treatment of epilepsy[J]. Curr Opin Neurol Neurosurg, 1993, 6:240-249. [10] Sunwoo JS, Kim JS. Cerebellar dysembryoplastic neuroepithelial tumor: report of a case and review of the literature[J]. J Neurol, 2017, 264:2318-2321. [11] Patira R, Nathan C, Zubkov S, Gutierrez C, Munyon C, Mukherjee A, Jacobson M. Occipital dysembryoplastic neuroepithelial tumor presenting as adult-onset temporal epilepsy[J]. Epilepsy Behav Case Rep, 2017, 8:92-95. [12] Stark J, Friedman E, Thompson S, Von Allmen G, Bhattacharjee M, Tandon N. Atypical presentations of dysembryoplastic neuroepithelial tumors[J]. Epilepsia, 2018, 59: E14-17. [13] Sontowska I, Matyja E, Malejczyk J, Grajkowska W. Dysembryoplastic neuroepithelial tumour: insight into the pathology and pathogenesis[J]. Folia Neuropathol, 2017, 55:1-13. [14] Takahashi A, Hong SC, Seo DW, Hong SB, Lee M, Suh YL. Frequent association of cortical dysplasia in dysembryoplastic neuroepithelial tumor treated by epilepsy surgery[J]. Surg Neurol, 2005, 64:419-427. [15] Li Y, Li B, Yang ZY, Li Z. The clinicopathological characteristics of non-specific variant of dysembryoplastic neuroepithelial tumor[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2016, 16:850-858.[李扬, 李斌, 杨智云, 李智. 非特殊型胚胎发育不良性神经上皮肿瘤临床病理学特征[J]. 中国现代神经疾病杂志, 2016, 16:850-858.] [16] Thom M, Toma A, An S, Martinian L, Hadjivassiliou G, Ratilal B, Dean A, McEvoy A, Sisodiya SM, Brandner S. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature[J]. J Neuropathol Exp Neurol, 2011, 70:859-878. [17] Lee D, Cho YH, Kang SY, Yoon N, Sung CO, Suh YL. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas[J]. J Surg Oncol, 2015, 111:359-364. [18] Kakkar A, Majumdar A, Kumar A, Tripathi M, Pathak P, Sharma MC, Suri V, Tandon V, Chandra SP, Sarkar C. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs)[J]. Epilepsy Res, 2016, 127:141-151. [19] Sung CO, Suh YL, Hong SC. CD34 and microtubule-associated protein 2 expression in dysembryoplastic neuroepithelial tumours with an emphasis on dual expression in non-specific types[J]. Histopathology, 2011, 59:308-317. [20] Padovani L, Colin C, Fernandez C, Maues de Paula A, Mercurio S, Scavarda D, Frassineti F, Adélaïde J, Loundou A, Intagliata D, Bouvier C, Lena G, Birnbaum D, Girard N, Figarella-Branger D. Search for distinctive markers in DNT and cortical grade Ⅱ glioma in children: same clinicopathological and molecular entities[J]? Curr Top Med Chem, 2012, 12:1683-1692. [21] Liu XQ, Shen YL, Yang WS. Dysembryoplastic neuroepithelial tumor: a clinicopathological analysis of four cases[J]. Zhen Duan Bing Li Xue Za Zhi, 2019, 26:582-586.[刘雪青, 沈艳玲,杨文圣. 胚胎发育不良性神经上皮肿瘤4例临床病理观察[J]. 诊断病理学杂志, 2019, 26:582-586.] [22] Heiland DH, Staszewski O, Hirsch M, Masalha W, Franco P, Grauvogel J, Capper D, Schrimpf D, Urbach H, Weyerbrock A. Malignant transformation of a dysembryoplastic neuroepithelial tumor (DNET) characterized by genome-wide methylation analysis[J]. J Neuropathol Exp Neurol, 2016, 75:358-365. [23] Tonetti DA, Ares WJ, Richardson RM, Hamilton RL, Lieberman FS. Long-term recurrence of dysembryoplastic neuroepithelial tumor: clinical case report[J]. Surg Neurol Int, 2017, 8:140. [24] Yang J, Kim SK, Kim KJ, Chae JH, Lim BC, Wang KC, Park SH, Phi JH. Satellite lesions of DNET: implications for seizure and tumor control after resection[J]. J Neurooncol, 2019, 143: 437-445. |